Literature DB >> 26262597

Simultaneous determination of six bioactive constituents of Guizhi Fuling Capsule in rat plasma by UHPLC-MS/MS: Application to a pharmacokinetic study.

Longshan Zhao1, Zhili Xiong2, Yang Sui2, Heyun Zhu2, Zhiyu Zhou2, Zhenzhong Wang3, Yiwu Zhao3, Wei Xiao3, Jianyang Lin4, Kaishun Bi5.   

Abstract

A rapid and selective ultra-high performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS) method was developed for simultaneous determination of gallic acid, amygdalin, albiflorin, paeoniflorin, paeonol and cinnamic acid, the major bioactive constituents of Guizhi Fuling Capsule in rat plasma using phenacetin as internal standard (IS). The plasma samples were pretreated by protein precipitation with acetonitrile after acidification and separated on a Waters BEH C18 column (50mm×2.1mm, 1.7μm) using gradient elution with a mobile phase consisting of water (containing 0.1% formic acid) and acetonitrile at a flow rate of 0.2mL/min. Mass spectrometric detection was performed on Micromass Quattromicro API mass spectrometer equipped with electrospray ionization source in multiple reaction monitoring (MRM) mode. The intra- and inter-day precisions (as relative standard deviation) were below 14.6% for all analytes, and the accuracies (as relative error) were within ±5.0%. The lower limits of quantification (LLOQ) were 10, 10, 5, 5, 25, 25ng/mL for gallic acid, amygdalin, albiflorin, paeoniflorin, paeonol and cinnamic acid, respectively. Extraction recovery, matrix effect and stability were satisfactory in rat plasma. This method was fully validated and applied to a pharmacokinetic study of the six bioactive constituents after oral administration of Guizhi Fuling Capsule to rats.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Guizhi Fuling Capsule; Pharmacokinetics; Rat plasma; UHPLC–MS/MS

Mesh:

Substances:

Year:  2015        PMID: 26262597     DOI: 10.1016/j.jchromb.2015.07.031

Source DB:  PubMed          Journal:  J Chromatogr B Analyt Technol Biomed Life Sci        ISSN: 1570-0232            Impact factor:   3.205


  4 in total

1.  Oral Administration of the Japanese Traditional Medicine Keishibukuryogan-ka-yokuinin Decreases Reactive Oxygen Metabolites in Rat Plasma: Identification of Chemical Constituents Contributing to Antioxidant Activity.

Authors:  Yosuke Matsubara; Takashi Matsumoto; Kyoji Sekiguchi; Junichi Koseki; Atsushi Kaneko; Takuji Yamaguchi; Yumiko Kurihara; Hiroyuki Kobayashi
Journal:  Molecules       Date:  2017-02-08       Impact factor: 4.411

2.  Guizhi Fuling Wan, a Traditional Chinese Herbal Formula, Sensitizes Cisplatin-Resistant Human Ovarian Cancer Cells through Inactivation of the PI3K/AKT/mTOR Pathway.

Authors:  Li Han; Xiaojuan Guo; Hua Bian; Lei Yang; Zhong Chen; Wenhua Zang; Jingke Yang
Journal:  Evid Based Complement Alternat Med       Date:  2016-05-18       Impact factor: 2.629

3.  Integrated identification, qualification and quantification strategy for pharmacokinetic profile study of Guizhi Fuling capsule in healthy volunteers.

Authors:  Yun-Xi Zhong; Xiao-Liang Jin; Shi-Yin Gu; Ying Peng; Ke-Rong Zhang; Bing-Chen Ou-Yang; Yu Wang; Wei Xiao; Zhen-Zhong Wang; Ji-Ye Aa; Guang-Ji Wang; Jian-Guo Sun
Journal:  Sci Rep       Date:  2016-08-16       Impact factor: 4.379

4.  Overcoming cisplatin resistance by targeting the MTDH-PTEN interaction in ovarian cancer with sera derived from rats exposed to Guizhi Fuling wan extract.

Authors:  Li Han; Xueyun Cao; Zhong Chen; Xiaojuan Guo; Lei Yang; Yubing Zhou; Hua Bian
Journal:  BMC Complement Med Ther       Date:  2020-02-17
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.